Thank you Larppis, for confirming that Dr. Liau did indeed say that UCLA is collaborating with BMS on the combo trial with: DCVax-L + PD-1 inhibitor + CSF-1 receptor inhibitor.
I do think it is possible that UCLA is collaborating with both BMS (BMY) & Merck (MRK).